Skip to content
Application 205429
- Type
- ANDA
- Sponsor
- ALVOGEN
Application Products#
Product, Drug, Ingredient table| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|
| 001 | DAPSONE | DAPSONE | TABLET;ORAL | 25MG | No | No |
| 002 | DAPSONE | DAPSONE | TABLET;ORAL | 100MG | No | No |
NDC Listings For This Application#
NDC, Name, Nonproprietary name table| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|
| 47781-333 | Dapsone | dapsone | Alvogen Inc. | ANDA | Current |
| 47781-333 | Dapsone | dapsone | Alvogen Inc. | ANDA | Current |
| 47781-333 | Dapsone | dapsone | Alvogen Inc. | ANDA | Current |
| 47781-334 | Dapsone | dapsone | Alvogen Inc. | ANDA | Current |
| 47781-334 | Dapsone | dapsone | Alvogen Inc. | ANDA | Current |
| 47781-334 | Dapsone | dapsone | Alvogen Inc. | ANDA | Current |